Skip to content

Clinical trials

Phase 3 Carcinoma, Renal Cell trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 3 Country / region: Russia Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20042
20063
20081
20102
20121
20131
20151
20162
20176
20181
20192
20202
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Active, not recruiting8
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb5
Hoffmann-La Roche4
Merck Sharp & Dohme LLC4
Pfizer4
GlaxoSmithKline2
AstraZeneca1
Bayer1
EMD Serono Research & Development Institute, Inc.1
Eisai Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell30
Kidney Neoplasms8
Neoplasms4
Neoplasm Metastasis3
Kidney Diseases2
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Transitional Cell1
Neoplasms by Site1
Ovarian Neoplasms1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.